|
Volumn 87, Issue 7, 2009, Pages 709-713
|
Diabetic macular oedema and visual loss: Relationship to location, severity and duration
|
Author keywords
Diabetic macular oedema; Diabetic retinopathy; Ruboxistaurin; Visual acuity
|
Indexed keywords
PLACEBO;
PROTEIN KINASE C;
RUBOXISTAURIN;
ENZYME INHIBITOR;
INDOLE DERIVATIVE;
MALEIMIDE DERIVATIVE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC MACULAR EDEMA;
DIABETIC RETINOPATHY;
DISEASE DURATION;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OPTICAL COHERENCE TOMOGRAPHY;
PHOTOGRAPHY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
ANTAGONISTS AND INHIBITORS;
FOLLOW UP;
MACULAR EDEMA;
MIDDLE AGED;
PATHOLOGY;
PATHOPHYSIOLOGY;
PHASE 3 CLINICAL TRIAL;
PHYSIOLOGY;
RETINA MACULA LUTEA;
SEVERITY OF ILLNESS INDEX;
TIME;
VISION DISORDERS;
DIABETIC RETINOPATHY;
DOUBLE-BLIND METHOD;
ENZYME INHIBITORS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INDOLES;
MACULA LUTEA;
MACULAR EDEMA;
MALE;
MALEIMIDES;
MIDDLE AGED;
PROTEIN KINASE C;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
VISION DISORDERS;
VISUAL ACUITY;
|
EID: 72349083592
PISSN: 1755375X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1755-3768.2009.01545.x Document Type: Article |
Times cited : (32)
|
References (9)
|